  Iron deficiency is a frequent complication of chronic kidney disease ( CKD) that is associated with a decrease in the quality of life of patients and an increase in the risk of other clinical complications. Iron therapy represents one of the fundamentals of patients with CKD. Sucrosomial The main objective of this study was to assess the economic impact of the oral iron Fisiogen Ferro Forte A 4-year budget impact model was developed for the period 2017-2020 for CKD patients with iron deficiency who were candidates for intravenous iron due to a lack of response to oral iron , from the perspective of the Spanish healthcare system. Three subgroups of CKD patients were included in the analysis: predialysis , peritoneal dialysis , and post-transplant. The intravenous iron formulations Ferinject The average annual budget savings due to an increase in Fisiogen Ferro Forte The increase in the use of Fisiogen Ferro Forte